Clinical Response to Poly(ADP-ribose) Polymerase Inhibitor in Metastatic Breast Cancer With a Germline Reduced-Penetrance BRCA2 Pathogenic Variant: A Molecular Tumor Board Discussion
Diocésio Alves Pinto de Andrade, Carlos Alberto Fruet Filho, Cristiane Alves Mendes, Eduardo Miguel Febrônio et autres
br (code pays fourni par la source)